Acticor Biotech (XPAR:ALACT) Other Long Term Assets : €0.52 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Other Long Term Assets?

Acticor Biotech's other long-term assets for the quarter that ended in Jun. 2023 was €0.52 Mil.

Acticor Biotech's quarterly other long-term assets increased from Jun. 2022 (€0.33 Mil) to Dec. 2022 (€0.48 Mil) and increased from Dec. 2022 (€0.48 Mil) to Jun. 2023 (€0.52 Mil).

Acticor Biotech's annual other long-term assets increased from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.20 Mil) and increased from Dec. 2021 (€0.20 Mil) to Dec. 2022 (€0.48 Mil).

Acticor Biotech Other Long Term Assets Historical Data

The historical data trend for Acticor Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Other Long Term Assets Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long Term Assets

Get a 7-Day Free Trial

0.01

0.20

0.48

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Long Term Assets	Get a 7-Day Free Trial				-	0.20	0.33	0.48	0.52

Acticor Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines